Results 61 to 70 of about 15,755,427 (366)
Targeting TGF-β signal transduction for fibrosis and cancer therapy
Molecular Cancer, 2022 Transforming growth factor β (TGF-β) has long been identified with its intensive involvement in early embryonic development and organogenesis, immune supervision, tissue repair, and adult homeostasis.
Dandan Peng +4 more
semanticscholar +1 more source
Sensors, 2022 Several detectors have been developed to measure radiation doses during radiotherapy. However, most detectors are not flexible. Consequently, the airgaps between the patient surface and detector could reduce the measurement accuracy.
Dong-Seok Shin +10 more
doaj +1 more source
Individualizing cancer therapy [PDF]
Leukemia & Lymphoma, 2010 In this issue of Leukemia and Lymphoma, Ngo and colleagues describe the predictive value of cyclin D1 expression as a predictor of bortezomib response in multiple myeloma. The ability to predict treatment response based on genetic expression would be of value, if it could be confirmed in a larger study.
Morie A, Gertz, Tamar, Tadmor
openaire +2 more sources
, 2014 Purpose: The main purpose of this study is to perform a treatment planning study on a synchronous bilateral non-small cell lung cancer case using three treatment modalities: uniform scanning proton therapy, RapidArc, and intensity modulated radiation ...
Zheng, Yuanshui; Department of Medical Physics, ProCure Proton Therapy Center, Oklahoma City, OK, USA. +6 more
core +1 more source
A TCR-based Chimeric Antigen Receptor
Scientific Reports, 2017 Effector T cells equipped with engineered antigen receptors specific for cancer targets have proven to be very efficient. Two methods have emerged: the Chimeric Antigen Receptors (CARs) and T-cell Receptor (TCR) redirection.
Even Walseng +8 more
doaj +1 more source
Nanomaterials for cancer therapy: current progress and perspectives
Journal of Hematology & Oncology, 2021 Cancer is a disease with complex pathological process. Current chemotherapy faces problems such as lack of specificity, cytotoxicity, induction of multi-drug resistance and stem-like cells growth.
Zhe Cheng +3 more
semanticscholar +1 more source
Neutrophil Extracellular Traps in Cancer Therapy Resistance
, 2022 Neutrophils and their products are increasingly recognized to have a key influence on cancer progression and response to therapy. Their involvement has been shown in nearly every aspect of cancer pathophysiology with growing evidence now supporting their
Jonathan J. Cools-Lartigue +7 more
core +1 more source
Recent advances in exosome-mediated nucleic acid delivery for cancer therapy
Journal of Nanobiotechnology, 2022 Cancer is a leading public health problem worldwide. Its treatment remains a daunting challenge, although significant progress has been made in existing treatments in recent years. A large concern is the poor therapeutic effect due to lack of specificity
Ying Zhang +10 more
semanticscholar +1 more source
Targeting non-coding RNAs to overcome cancer therapy resistance
Signal Transduction and Targeted Therapy, 2022 It is now well known that non-coding RNAs (ncRNAs), rather than protein-coding transcripts, are the preponderant RNA transcripts. NcRNAs, particularly microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), are widely ...
Baoqing Chen +5 more
semanticscholar +1 more source
Chinese Expert Consensus on Oncology Multimorbidity Management (2025 Edition)
Zhongliu Fangzhi YanjiuAgainst the backdrop of accelerated population aging, the prevalence of comorbidities in patients with malignant tumors has risen by 0.54% annually, presenting a significant challenge to clinical oncology.
Chinese Society of Clinical Oncology (CSCO) Committee of Experts on Cancer Supportive and Rehabilitation Therapy
doaj +1 more source